68 related articles for article (PubMed ID: 2602219)
1. Clinicopathological study of Ki-1-positive lymphomas.
Tashiro K; Kikuchi M; Takeshita M; Yoshida T; Ohshima K
Pathol Res Pract; 1989 Oct; 185(4):461-7. PubMed ID: 2602219
[TBL] [Abstract][Full Text] [Related]
2. Ki-1 antigen expression defines a favorable clinical subset of non-B cell non-Hodgkin's lymphoma.
Offit K; Ladanyi M; Gangi MD; Ebrahim SA; Filippa D; Chaganti RS
Leukemia; 1990 Sep; 4(9):625-30. PubMed ID: 2168505
[TBL] [Abstract][Full Text] [Related]
3. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
Miettinen M
Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
[TBL] [Abstract][Full Text] [Related]
4. Immunophenotypic analysis of extranodal non-Hodgkin's lymphomas in the oral cavity.
Takahashi H; Fujita S; Okabe H; Tsuda N; Tezuka F
Pathol Res Pract; 1993 Apr; 189(3):300-11. PubMed ID: 8332573
[TBL] [Abstract][Full Text] [Related]
5. Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype.
Delabie J; Vandenberghe E; Kennes C; Verhoef G; Foschini MP; Stul M; Cassiman JJ; De Wolf-Peeters C
Am J Surg Pathol; 1992 Jan; 16(1):37-48. PubMed ID: 1728195
[TBL] [Abstract][Full Text] [Related]
6. [T-cell-rich B-cell lymphoma: multifactorial study of 4 cases].
Moreno MM; Fernández-Flores A; Paradela A; RodrÃguez JM; Ageitos A; Gonzalo I; Marcos B; Robledo M; Rivas C
Sangre (Barc); 1995 Dec; 40(6):471-7. PubMed ID: 8850230
[TBL] [Abstract][Full Text] [Related]
7. Cytokine production (IL-1 alpha, IL-1 beta, and TNF alpha) and endothelial cell activation (ELAM-1 and HLA-DR) in reactive lymphadenitis, Hodgkin's disease, and in non-Hodgkin's lymphomas. An immunocytochemical study.
Ruco LP; Pomponi D; Pigott R; Stoppacciaro A; Monardo F; Uccini S; Boraschi D; Tagliabue A; Santoni A; Dejana E
Am J Pathol; 1990 Nov; 137(5):1163-71. PubMed ID: 1700619
[TBL] [Abstract][Full Text] [Related]
8. Leu-M1--a marker for Reed-Sternberg cells in Hodgkin's disease. An immunoperoxidase study of paraffin-embedded tissues.
Pinkus GS; Thomas P; Said JW
Am J Pathol; 1985 May; 119(2):244-52. PubMed ID: 3887932
[TBL] [Abstract][Full Text] [Related]
9. Bauhinia purpurea--a new paraffin section marker for Reed-Sternberg cells of Hodgkin's disease. A comparison with Leu-M1 (CD15), LN2 (CD74), peanut agglutinin, and Ber-H2 (CD30).
Sarker AB; Akagi T; Jeon HJ; Miyake K; Murakami I; Yoshino T; Takahashi K; Nose S
Am J Pathol; 1992 Jul; 141(1):19-23. PubMed ID: 1352944
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic expression of non-Hodgkin's lymphomas in China.
Xu LZ; Tu LY; Liu YF; Hsu SM; Qiu BS; Li ZX
J Natl Cancer Inst; 1984 Sep; 73(3):635-8. PubMed ID: 6236322
[TBL] [Abstract][Full Text] [Related]
11. Large anaplastic cell Ki-1 positive malignant lymphoma with peculiar endocytotic vacuoles.
Le Tourneau A; Audouin J; Diebold J; Pujade-Lauraine E; Bernadou A
Pathol Res Pract; 1990 Dec; 186(6):784-92; discussion 792-4. PubMed ID: 1964733
[TBL] [Abstract][Full Text] [Related]
12. Hodgkin's disease and CD30-positive anaplastic large cell lymphomas--a continuous spectrum of malignant disorders. A quantitative morphometric and immunohistologic study.
Leoncini L; Del Vecchio MT; Kraft R; Megha T; Barbini P; Cevenini G; Poggi S; Pileri S; Tosi P; Cottier H
Am J Pathol; 1990 Nov; 137(5):1047-57. PubMed ID: 2173409
[TBL] [Abstract][Full Text] [Related]
13. Primary and secondary cutaneous Ki-1+ (CD30+) anaplastic large cell lymphomas. Morphologic, immunohistologic, and clinical-characteristics.
Kaudewitz P; Stein H; Dallenbach F; Eckert F; Bieber K; Burg G; Braun-Falco O
Am J Pathol; 1989 Aug; 135(2):359-67. PubMed ID: 2551170
[TBL] [Abstract][Full Text] [Related]
14. Differential diagnosis of L26-positive, CD15-negative Hodgkin's disease and large B-cell lymphoma with a high content of reactive T-cells: a morphologic and immunohistochemical study.
Nguyen DT; Diamond LW; Hansmann ML; Fischer R
Hematopathol Mol Hematol; 1996; 10(3):135-50. PubMed ID: 8878732
[TBL] [Abstract][Full Text] [Related]
15. Expression of bcl-2 oncogene product in primary non-Hodgkin's malignant lymphoma of the oral cavity.
Takahashi H; Kawazoe K; Fujita S; Okabe H; Hideshima K; Tsuda N; Tezuka F
Pathol Res Pract; 1996 Jan; 192(1):44-53. PubMed ID: 8685041
[TBL] [Abstract][Full Text] [Related]
16. Phenotypes and phorbol ester-induced differentiation of human histiocytic lymphoma cell lines (U-937 and SU-DHL-1) and Reed-Sternberg cells.
Hsu SM; Hsu PL
Am J Pathol; 1986 Feb; 122(2):223-30. PubMed ID: 3511721
[TBL] [Abstract][Full Text] [Related]
17. Production and characterization of a monoclonal antibody that binds Reed-Sternberg cells.
Hecht TT; Longo DL; Cossman J; Bolen JB; Hsu SM; Israel M; Fisher RI
J Immunol; 1985 Jun; 134(6):4231-6. PubMed ID: 3157756
[TBL] [Abstract][Full Text] [Related]
18. Anaplastic large cell Ki-1 lymphoma. Delineation of two morphological types.
Chan JK; Ng CS; Hui PK; Leung TW; Lo ES; Lau WH; McGuire LJ
Histopathology; 1989 Jul; 15(1):11-34. PubMed ID: 2548945
[TBL] [Abstract][Full Text] [Related]
19. Two novel cultured cell lines, A3/Kawakami and A4/Fukuda, derived from malignant lymphoma of B(non-T)-cell nature of the gastrointestinal tract.
Hirose M; Minato K; Tobinai K; Shimoyama M; Watanabe S; Abe T; Deura K
Gan; 1983 Feb; 74(1):106-15. PubMed ID: 6601597
[TBL] [Abstract][Full Text] [Related]
20. Lymphohistiocytic T-cell lymphoma (anaplastic large cell lymphoma CD30+/Ki-1 + with a high content of reactive histiocytes).
Pileri S; Falini B; Delsol G; Stein H; Baglioni P; Poggi S; Martelli MF; Rivano MT; Mason DY; Stansfeld AG
Histopathology; 1990 Apr; 16(4):383-91. PubMed ID: 2163351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
